Clinical trial
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperhomocysteinemia in Alzheimer's Disease
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2023
- Completion date
- March 1, 2026
- Enrollment
- 43 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, homocystinemia